臨床研究等提出・公開システム

Scientific Title	Development of cognitive function evaluation and training methods using AI robots
Public Title	Development of cognitive function evaluation and training methods using AI robots

Contact for Scientific Queries	Name	Takeda Shuko
	Affiliation	Osaka Psychiatric Medical Center
	Address	Miyanosaka 3-16-21 Hirakata-shi, Osaka
	Telephone	+81-72-847-3261
	E-mail	takeda@cgt.med.osaka-u.ac.jp
Contact for Public Queries	Name	Deguchi Jiro
	Affiliation	Osaka Psychiatric Medical Center
	Address	Miyanosaka 3-16-21 Hirakata-shi, Osaka
	Telephone	+81-72-847-3261
	E-mail	deguchij@mh-opho.jp

Recruitment status	Recruiting

Anticipated date of first enrollment		Nov. 17, 2021
Target sample size		100
Study Type		Interventional
Study Design	allocation	single arm study
	masking	open(masking not used)
	control	uncontrolled control
	assignment	single assignment
	purpose	prevention purpose
Key inclusion & exclusion criteria	Inclusion Criteria	People who are normal in cognitive function, mild cognitive impairement or dementia.
	Exclusion Criteria	People who are severe hearing, visual or speech impaired People who cannot operate the touch panel because of movement disorder
	Age Minimum	40age old over
	Age Maximum	No limit
	Gender	Both
Health Condition(s) or Problem(s) Studied		Mild cognitive impairment, dementia
Intervention(s)		AI(artificial intelligence) robots (ZUKKU, Hatapro Co., Ltd.) will be rented to research collaborators for a certain period of time, and cognitive function training programs installed on AI robots will be regularly undertaken at the research collaborators' homes.
Health Condition(s) Keyword		Mild cognitive impairment, dementia
Intervention(s) Keyword		robot, training for cognitive function
Health Condition(s) Code		D003704, D060825
Primary Outcome(s)		Before and after the training for cognitive function using AI robot, the gaze measurement device (Gazefinder, JVC KENWOOD) will be used to record the subject's gaze movement to task images for about 3-5 minutes (eye tracking method), and the effect of training will be evaluated.
Secondary Outcome(s)		none

Primary Sponsor	Osaka Psychiatric Medical Center

Name of Certified Review Board	Institutional Review Board, Osaka Psychiatric Medical Center
Address	Miyanosaka 3-16-21 Hirakata-shi, Osaka
Telephone	+81-72-847-3261
E-Mail	deguchij@mh-opho.jp
Approval Status	Approval
Date of approval	Nov. 16, 2021

Plan to share IPD	No

Countries of Recruitment（Except Japan）	none